New UTI Guidelines Reveal Major Evidence Gaps
Conexiant
November 4, 2024
A new consensus statement in JAMA Network Open highlights evidence gaps in urinary tract infection management despite their common occurrence.
Out of 37 clinical questions, only 6 received clear evidence-based recommendations from the international expert panel.
Cranberry products and topical estrogen were identified as effective for reducing recurrent UTIs in specific populations.
The guidelines specify treatment durations for acute cystitis and recommend specific prophylactic dosing for various medications.
Research gaps include the need for high-quality data on prevention, diagnosis, and treatment of UTIs, particularly in special populations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: